Cybelle Contraindications

If the patient is allergic (hypersensitive) to ethinylestradiol, cyproterone acetate or any ingredients of Cybelle.
Patients has or has ever had disorder affecting blood circulation, in particular, those conditions relating to thrombosis: Formation of a blood clot in the blood vessels of the legs (deep vein thrombosis), the lungs (pulmonary embolism), the heart (heart attack) or other parts of the body; stroke (caused by a blood clot or a rupture of a blood vessel in the brain); condition that may be a 1st sign of a heart attack (eg, angina pectoris or chest pain) or stroke (eg, transient ischemic attack or small reversible stroke), history of migraine accompanied by visual symptoms, speech disability, or weakness or numbness in any part of the body; diabetes mellitus with blood vessel damage; pancreatitis (an inflammation of pancreas) associated with high levels of fatty substances in the blood; jaundice (yellowing of the skin) or severe liver disease; cancer that may grow under the influence of sex hormones (eg, of the breast or genital organs); benign malignant liver tumor; unexplained vaginal bleeding.
If any of these conditions appear for the 1st time while using Cybelle, stop taking it at once and consult the doctor. In the meantime, use non-antiandrogen therapy measures.
Cybelle is not to be used by males.
Use in Pregnancy: Cybelle must not be used by women who are pregnant or who think they might be pregnant. If the patient suspects that she is pregnant while using Cybelle, the patient should consult the doctor as soon as possible.
Use in Lactation: Cybelle must not be used during breastfeeding.